Table 2_Feasibility of integrating genetic risk and digital health tools for cardiovascula

A protocol document for a pilot randomized controlled feasibility study involving 120 adults aged 40–69 with metabolic syndrome. The FitPreV study aims to assess the integration of polygenic risk scores and wearable health devices into primary cardiovascular prevention within the Italian National Health Service. The document was authored by Diego Maria Tona and last updated on 2026-05-29.

Use Cases

• Designing a similar feasibility study based on the described four-arm randomized controlled trial protocol
• Analyzing barriers to adoption of digital health tools in general practice based on the study's feasibility indicators
• Modeling changes in cardiovascular risk using the SCORE2 algorithm based on the secondary outcome measures mentioned

Strengths

• Protocol is clearly structured with defined objectives, methods, and expected results for a 120-participant study.
• Includes specific feasibility indicators like recruitment/retention rates and acceptability, providing a framework for evaluation.
• Data collection is planned at multiple time points (baseline, 1, 6, and 12 months) for longitudinal assessment.

Limitations

• The dataset is a 78.1 KB protocol document (DOCX), not the underlying study data, which limits direct analysis.
• Row count and column-level documentation for the actual trial data are absent; field semantics must be inferred after download.
• Last updated 2026-05-29; freshness should be verified as this is a future date.

Provenance

Source

figshare

Collection Method

Pilot randomized controlled feasibility study protocol.

Time Range

Study involves data collection at baseline, 1, 6, and 12 months.

Freshness

Last updated 2026-05-29 06:18:26

Geography

Study focuses on implementation within the Italian National Health Service (SSN).